Publication | Closed Access
Rucaparib in patients with BAP1-deficient or BRCA1-deficient mesothelioma (MiST1): an open-label, single-arm, phase 2a clinical trial
108
Citations
23
References
2021
Year
MedicinePathologyImmune Checkpoint InhibitorBrca1-deficient MesotheliomaCancer TreatmentOncologyRadiation OncologyCancer Research
| Year | Citations | |
|---|---|---|
Page 1
Page 1